Comments
Loading...

Apollomics Inc (APLM) Stock Price, Quote, News & History

APLMNASDAQ
$19.79
0.593.07%
At close: Feb 13, 4:00 PM EST
$20.54
0.753.79%
After Hours: Jan 8, 9:28 AM EST

Key Statistics

Open
$19.09
Close
$19.79
Volume / Avg.
7.44K / 26.24K
Day Range
$19.09 - $20.78
52 Wk Range
3.66 - 42.12
Market Cap
$44.02M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
56
Short Interest
0.92%
Days to Cover
1.12

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-20.38M
Investing Cash Flow (TTM)
284.00K
Financing Cash Flow (TTM)
-3.73M
Free Cash Flow (TTM)
-20.38M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-23.83M

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$39.91M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
2.49
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-138.75%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$2.05

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
$0
LT Debt Repayment (TTM)
-$133.00K
Total Cash
$2.09M
Debt to Equity
-
Issuance of Debt (TTM)
-$133.00K
Repayment of Debt (TTM)
-$3.64M

Key Statistics

Open
$19.09
Close
$19.79
Volume / Avg.
7.44K / 26.24K
Day Range
$19.09 - $20.78
52 Wk Range
3.66 - 42.12
Market Cap
$44.02M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
56
Short Interest
0.92%
Days to Cover
1.12

About

Sector
Health Care
Industry
Biotechnology
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pat...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
APLM
GLTO

FAQ

Q

How do I buy Apollomics (APLM) stock?

A

You can purchase shares of Apollomics (NASDAQ:APLM) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for Apollomics (APLM) stock?

A

Apollomics has a consensus price target of $8.50.

Q

What is the current price for Apollomics (APLM)?

A

The stock price for Apollomics (NASDAQ: APLM) is $20.54 last updated January 8, 2026 at 9:28 AM EST.

Q

Does Apollomics (APLM) pay a dividend?

A

There are no upcoming dividends for Apollomics.

Q

When is Apollomics (NASDAQ:APLM) reporting earnings?

A

Apollomics does not have any upcoming earnings scheduled.

Q

Is Apollomics (APLM) going to split?

A

There is no upcoming split for Apollomics.

Q

What sector and industry does Apollomics (APLM) operate in?

A

Apollomics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.